Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Schistosomiasis - Overview
Schistosomiasis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Schistosomiasis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Schistosomiasis - Companies Involved in Therapeutics Development
Merck KGaA
Pai Life Sciences Inc
Tongli Biomedical Co Ltd
Villya Pharmaceuticals
Schistosomiasis - Drug Profiles
Inlasel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
intestil schistosomiasis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
intestil schistosomiasis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
L-Praziquantel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
P-MAPA - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
praziquantel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
praziquantel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
R-praziquantel - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
schistosomiasis vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Schistosomiasis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Schistosomiasis - Dormant Projects
Schistosomiasis - Product Development Milestones
Featured News & Press Releases
Jun 01, 2021: IVI to design adaptive Phase Ib/IIa trial for schistosomiasis vaccine
Jan 18, 2018: George Washington University: Schistosoma vaccine to enter phase Ib clinical trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Schistosomiasis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Schistosomiasis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Schistosomiasis - Pipeline by Merck KGaA, 2021
Schistosomiasis - Pipeline by Pai Life Sciences Inc, 2021
Schistosomiasis - Pipeline by Tongli Biomedical Co Ltd, 2021
Schistosomiasis - Pipeline by Villya Pharmaceuticals, 2021
Schistosomiasis - Dormant Projects, 2021